4.665USD+9.51%Mkt Cap: 111.62M USDP/E: —Last update: 2026-05-26
Exagen Inc. designs, develops, and commercializes various testing products under the AVISE brand in the United States. The company enables healthcare providers to care for patients through the diagnosis, prognosis, and m…
Industry Peers
Diagnostics & Research166.94BUSDP/E 24.7
122.72BUSDP/E 33.6
44.05BUSDP/E 41.1
34.33BCHFP/E 37.8
33.46BUSDP/E 43.3
32.69BUSDP/E 25.5
28.46BUSD—
27.28BUSDP/E 20.3
Indicators:|
Key Statistics
Company
Market Cap111.62M USD
Enterprise Value108.80M USD
Revenue (TTM)68.38M USD
Gross Profit38.80M USD
Net Income (TTM)-19.95M USD
Revenue/Share2.988 USD
Last Price4.665 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees216
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS30068X1037
Valuation
P/E (Trailing)—
P/E (Forward)-9.93
PEG—
EV/EBITDA-9.19
EV/Revenue1.59
P/S1.51
P/B5.60
EPS (TTM)-0.90
EPS (Forward)-0.43
52W Range
2.59022% of range12.23
52W High12.23 USD
52W Low2.590 USD
Profitability
Gross Margin58.28%
Oper. Margin-19.73%
EBITDA Margin-17.32%
Profit Margin-29.97%
ROE-114.34%
ROA-34.39%
Growth
Revenue Growth11.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-13.63M USD
CapEx (TTM)641.00K USD
FCF Margin-13.26%
FCF Yield-8.12%
Net Debt5.63M USD
Net Debt/EBITDA-0.48
Balance Sheet
Debt/Equity1.47
Current Ratio3.47
Quick Ratio2.97
Book Value/Sh0.7620 USD
Cash/Share0.8900 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)8.667 USD
Target Range8.000 USD – 10.00 USD
# Analysts6
Ownership
Shares Out.24.16M
Float16.28M
Insiders22.91%
Institutions53.02%
Short Interest
Short Ratio3.8d
Short % Float3.31%
Short % Out.3.00%
Shares Short724.68K
Short (prev mo.)1.53M
Technical
SMA 503.099 (+50.5%)
SMA 2006.568 (-29.0%)
Beta1.81
S&P 52W Chg28.31%
Avg Vol (30d)483.59K
Avg Vol (10d)982.99K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—